Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-18

Clinical Trial Update: Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy and safety of obefazimod in adults with moderately to severely active Crohn's disease; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Obefazimod (obefazimod)

Snippet

Sponsor: Abivax S.A. | Conditions: Moderately to Severely Active Crohn Disease | Phase 2 | Status: RECRUITING